StockData
Allogene Therapeutics, Inc. logo

Allogene Therapeutics, Inc. (ALLO) stock

ALLONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 3/30
$0.74−0.06 (-7.79%)

Close on Nov 17, 2026Market cap $257.08MP/E –Yield 0.00%

Allogene Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Allogene Therapeutics's market cap was $310.85M on Nov 11, 2026, against $325.82M a year earlier. Over the last 5 years it ranged from $247.02M to $2.13B, with a median of $549.80M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$310.85M+1.7%
2025Dec 31, 2025$305.73M-31.5%
2024Dec 31, 2024$446.24M-17.3%
2023Dec 29, 2023$539.84M-40.4%
2022Dec 30, 2022$905.96M-57.4%
2021Dec 31, 2021$2.13B-39.8%
2020Dec 31, 2020$3.53B+11.4%
2019Dec 31, 2019$3.17B+276.1%
2018Dec 31, 2018$842.12M–

More Allogene Therapeutics figures

See a number that looks wrong?